The following data is part of a premarket notification filed by Quinnova Pharmaceuticals with the FDA for Neosalus.
Device ID | K070309 |
510k Number | K070309 |
Device Name: | NEOSALUS |
Classification | Dressing, Wound, Drug |
Applicant | QUINNOVA PHARMACEUTICALS 301SOUTH STATE STREET SUITE NOO1 Newtown, PA 18940 |
Contact | Jeffrey Day |
Correspondent | Jeffrey Day QUINNOVA PHARMACEUTICALS 301SOUTH STATE STREET SUITE NOO1 Newtown, PA 18940 |
Product Code | FRO |
CFR Regulation Number | 510(k) Premarket Notification [🔎] |
Decision | Substantially Equivalent (SESE) |
Type | Traditional |
3rd Party Reviewed | No |
Combination Product | Yes |
Date Received | 2007-02-01 |
Decision Date | 2008-09-12 |
Summary: | summary |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
NEOSALUS 77557887 3677679 Live/Registered |
GLENMARK THERAPEUTICS INC., USA 2008-08-28 |
NEOSALUS 77556490 3677674 Live/Registered |
GLENMARK THERAPEUTICS INC., USA 2008-08-27 |